Journal: bioRxiv
Article Title: MUC2 Expression Modulates Immune Infiltration in Colorectal Cancer
doi: 10.1101/2024.08.06.594842
Figure Lengend Snippet: A. Box plot of adherence junction enrichment score (ES) in HT-29 and LS-174T. The ES is up-regulated in HT-29 MUC2 K.O. compared to CTRL (p=0.041) (student t-test). In contrast, the ES is down-regulated in LS-174T MUC2 K.O. compared to CTRL (p=0.047) (student t-test). B. Representative capillary western blot (CWB) results of E-cadherin, N-cadherin and Vimentin expression in human fetal fibroblast (HFF), Hela, HT-29 CTRL and HT-29 MUC2 K.O. (N=2 technical replicates). C. Representative capillary western blot (CWB) results of E-cadherin, N-cadherin and Vimentin expression in HFF, Hela, LS-174T CTRL and LS-174T MUC2 K.O. (N=2 technical replicates). D. Quantification of band intensity of E-cadherin, N-cadherin and Vimentin normalized to beta actin expression in HFF, Hela, HT-29 CTRL and HT-29 MUC2. (N=2, technical replicates). E. Quantification of band intensity of E-cadherin, N-cadherin and Vimentin normalized to beta actin expression in HFF, Hela, LS-174T CTRL and LS-174T MUC2 K.O.. (N=2, technical replicates).
Article Snippet: Mouse anti human E-Cadherin (R&D systems, #MAB1838) diluted at 0.5ug/ml, mouse anti human N-Cadherin (Novus Biologicals, #NBP1-48309) diluted at 1 in 10, mouse anti human Vimentin (Novus Biologicas, #NBP1-92687) diluted at 1 in 25 and anti β-actin (Licor, #926-42212) diluted at 1 in 100 were used as primary antibody.
Techniques: Western Blot, Expressing